SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

PAULA, Ana Patrícia de et al. Clinical investigations for SUS, the Brazilian public health system. Sao Paulo Med. J. [online]. 2012, vol.130, n.3, pp. 179-186. ISSN 1516-3180.  http://dx.doi.org/10.1590/S1516-31802012000300008.

    1. Brasil. Presidência da República. Casa Civil. Subchefia para Assuntos Jurídicos. Constituição da República Federativa do Brasil de 1988. Available from: http://www.planalto.gov.br/ccivil_03/Constituicao/Constituicao.htm. Accessed in 2011 (Oct 22). [ Links ]

    2. Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Decit 10 anos. Brasília: Ministério da Saúde; 2010. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/decit_10anos.pdf. Accessed in 2011 (Oct 22). [ Links ]

    3. Guimarães R, Santos LMP, Angulo-Tuesta A, Serruya SJ. Defining and implementing a National Policy for Science, Technology, and Innovation in Health: lessons from the Brazilian experience. Cad Saúde Pública = Rep Public Health. 2006;22(9):1775-85. [ Links ]

    4. Brazil. Ministry of Health. Secretariat of Science, Technology and Strategic Inputs. Department of Science and Technology. National Agenda of Priorities in Health Research - Brazil. Brasília: Ministério da Saúde; 2006. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/agenda_ingles.pdf. Accessed in 2011 (Oct 22). [ Links ]

    5. Ministério da Saúde. Rede Nacional de Pesquisa Clínica do Brasil: respostas e redução da dependência estrangeira [National clinical research network: Brazilian response and mitigation of international dependency]. Rev Saúde Pública = J Public Health. 2010;44(3):575-8. [ Links ]

    6. Brasil. Ministério da Saúde. Conselho Nacional de Saúde. 2 Conferência Nacional de Ciência, Tecnologia e Inovação em Saúde, Brasília, 25 a 28 de julho de 2004. Brasília: Ministério da Saúde; 2004. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/2CNCTISfinal.pdf. Accessed in 2011 (Oct 22). [ Links ]

    7. Association of American Medical Colleges Task Force on Clinical Research 2000. Washington: Association of American Medical Colleges; 1999. [ Links ]

    8. Agência Européia para Avaliação de Produtos Medicinais. Unidade de Avaliação de Medicamentos Humanos. Manual para a Boa Prática Clínica. Versão harmonizada tripartite (USA, Europa e Japão) elaborada pela Conferência Internacional de Harmonização (ICH). Available from: www.ufrgs.br/bioetica/gcpport.htm. Accessed in 2011 (Oct 11). [ Links ]

    9. Marzochi KBF. Pesquisa clínica ampliada: conceito e prática. Available from: http://www.fiocruz.br/pesquisaclinica/media/Pesquisa clinica Ampliada - Keyla.pdf. Accessed in 2011 (Oct 28). [ Links ]

    10. Brasil. Ministério da Saúde. Departamento de Ciência e Tecnologia. Pesquisa Saúde. Departamento de Ciência e Tecnologia (Decit/SCTIE/MS). Available from: http://www.saude.gov.br/pesquisasaude. Accessed in 2011 (Oct 28). [ Links ]

    11. Organização para a Cooperação e Desenvolvimento Econômico. Frascati Manual. Paris: OCDE; 1993. [ Links ]

    12. Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Medicamentos. Considerações e definições para Pesquisa Clínica. Available from: http://www.anvisa.gov.br/medicamentos/pesquisa/def.htm. Accessed in 2011 (Oct 11). [ Links ]

    13. Quental C, Salles Filho S. Ensaios clínicos: capacitação nacional para avaliação de medicamentos e vacinas [Clinical Trials: Brazilian capability to evaluate drugs and vaccines]. Rev Bras Epidemiol. 2006;9(4):408-24. [ Links ]

    14. Brasil. Conselho Nacional de Saúde. Resolução n 251, de 07 de agosto de 1997. Aprova as normas de pesquisa envolvendo seres humanos para a área temática de pesquisa com novos fármacos, medicamentos, vacinas e testes diagnósticos. Available from: http://www.datasus.gov.br/conselho/resol97/res25197.htm. Accessed in 2011 (Oct 22). [ Links ]

    15. Zago MA. A pesquisa clínica no Brasil [Clinical research in Brazil]. Ciênc Saúde Coletiva. 2004;9(2):363-74. [ Links ]

    16. World Health Organization. Neglected tropical diseases. Frequently asked questions. Available from: http://www.who.int/neglected_diseases/faq/en/index5.html. Accessed in 2011 (Oct 22). [ Links ]

    17. Caramori CA, Barraviera B. Universities and neglected diseases: it is not enough to have the knowledge, it must be applied. J Venom Anim Toxins Incl Trop Dis. 2011;17(1):1-3. [ Links ]

    18. Machado PR, Ampuero J, Guimarães LH, et al. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS Negl Trop Dis. 2010;4(12):e912. [ Links ]

    19. Costa GC, da Costa Rocha MO, Moreira PR, et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis. 2009;199(3):451-4. [ Links ]

    20. Gomes FS, Spínola C de V, Ribeiro HA, et al. Wound-healing activity of a proteolytic fraction from Carica candamarcensis on experimentally induced burn. Burns. 2010;36(2):277-83. [ Links ]

    21. Pacheco S. Pesquisadores brasileiros criam exame molecular que reduz de oito para quatro horas o diagnóstico da gripe A. Correio Brasiliense, 26/06/2010. Available from: http://www.correiobraziliense.com.br/app/noticia/ciencia-e-saude/2010/06/26/interna_ciencia_saude,199542/index.shtml. Accessed in 2011 (Oct 11). [ Links ]

    22. Gillum LA, Gouveia C, Dorsey ER, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6(2):e16837. [ Links ]

    23. Rothwell PM. Funding for practice-oriented clinical research. Lancet. 2006;368(9532):262-6. [ Links ]

    24. Rawlins M. A new era for UK clinical research? Lancet. 2011;377(9761):190-2. [ Links ]

    25. Reihart D, Platonov P. Clinical trials in Russia: growing experience and revision of regulations. International Journal of Pharmaceutical Medicine. 2005;19(2):73-6. Available from: http://www.ingentaconnect.com/content/adis/ipm/2005/00000019/00000002/art00002. Accessed in 2011 (Nov 4). [ Links ]

    26. Vlassov V. Russian clinical research is threatened by ban on export of samples. BMJ. 2007;334(7606):1237. [ Links ]

    27. World Health Organization. News. Clinical trials in India: ethical concerns. Bulletin of the World Health Organization. 2008;86(8):581-2. Available from: http://www.who.int/bulletin/volumes/86/8/08-010808.pdf. Accessed in 2011 (Nov 4). [ Links ]

    28. Srinivasan S. Ethical concerns in clinical trials in India: an investigation. Centre for Studies in Ethics and Rights, Mumbai, India, 2009. Available from: http://www.fairdrugs.org/uploads/files/Ethical_concerns_in_clinical_trials_in_India_An_investigation.pdf. Accessed in 2011 (Oct 11). [ Links ]

    29. Iype G. Clinical trials: why India is irresistible. Available from: http://www.rediff.com/money/2004/dec/22spec.htm. Accessed in 2011 (Oct 28). [ Links ]

    30. Hu Y, Huang Y, Ding J, et al. Status of clinical research in China. Lancet. 2011;377(9760):124-5. [ Links ]

    31. Gevers W. Clinical research in South Africa: a core asset under pressure. Lancet. 2009;374(9692):760-2. [ Links ]

    32. Siegfried N, Volmink J, Dhansay A. Does South Africa need a national clinical trials support unit? S Afr Med J. 2010;100(8):521-4. [ Links ]